Thanks to the Republican tax legislation, pharmaceutical stocks are set to continue their heady northward trajectory in 2018. Source: BioSpace

The drug showed a significant, clinically meaningful and fast-acting improvement in depression symptoms compared to an intranasal placebo. Source: BioSpace

The drugmaker intends to expand development of therapeutic antibodies at the lab. Source: BioSpace

Menlo Therapeutics filed on Thursday with the SEC to raise up to $98M in an IPO. Source: BioSpace

ANI Phamaceuticals funded the acquisitions through a combination of cash and debt. Source: BioSpace

A look at a few biotechs which should outperform the market in 2018: Source: BioSpace

The parts expect the closing in the first quarter 2018. Source: BioSpace

Evan Greebel was found guilty by a federal jury in Brooklyn of charges he conspired to commit wire fraud and securities fraud. Source: BioSpace

From 1997 through 2013, there was an average of 27 novel drugs approved in the U.S. per year. Source: BioSpace

Celgene has been unloading some of its shares in two of its investments, CRISPR Therapeutics and Atara Biotherapeutics. Source: BioSpace